Lord, Abbett & Co. LLC Evolus, Inc. Transaction History
Lord, Abbett & Co. LLC
- $29.9 Billion
- Q2 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 806,764 shares of EOLS stock, worth $14.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
806,764
Previous 830,532
2.86%
Holding current value
$14.1 Million
Previous $11.6 Million
24.72%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding EOLS
# of Institutions
163Shares Held
49.1MCall Options Held
453KPut Options Held
14K-
Perceptive Advisors LLC New York, NY5.75MShares$101 Million1.81% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$84.7 Million6.42% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$70.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$52.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$50.9 Million2.11% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $981M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...